Replies to post #163385 on Cytodyn Inc (CYDY)

[misiu143]

With my observation I have little different opinion..

First no one yet could explain to me what FDA did with our combo in HIV..

Why having efficacy of 81% , with 350 mg of leronlimab , results in February 2018 , and not one serious side effect , drug for dying HIV drug resistant patients , we not approved yet , when other 2 drugs approved are...

Maraviroc with efficacy of 45% and severe side effects ,

And Ibalizumab with IV infusion , some side effects and 43% efficacy..

IMO as always..

[3X Charm]

Your recent posts acknowledge the limitations of CYDY CEO and leadership. I was blasted 12 months ago when the deficiencies of MGT were clearly outlined. I guess the early adopters are always viewed as being wrong.